Interaction between Comorbidity and Cancer
Open Access
- 1 January 2007
- journal article
- research article
- Published by SAGE Publications in Cancer Control
- Vol. 14 (1) , 13-22
Abstract
Background: Older patients have an average of three comorbidities in addition to their cancer. Oncologic studies have usually ignored this aspect when adjusting for confounders. There is mounting evidence that comorbidity interacts with risk, survival, disease progression, and treatment of elderly patients with cancer. The strength of many of these interactions increases with age. Methods: A review of the literature was undertaken regarding two of these interactions: cancer risk and prognosis. Results: In older patients, the risk and behavior of cancer can be strongly affected by comorbidities and their related treatment. Rather than a blanket effect, this effect might be attached to groups of syndromes with common pathophysiologic mechanisms. This is notably true for metabolic disorders and inflammatory diseases. Conclusions: In addition to focusing on the influence of cancer treatment on comorbidity or on the effect of comorbidity in delivering cancer treatment, future endeavors will need to consider the direct impact of comorbidity on the risk and the behavior of the cancer in elderly patients.Keywords
This publication has 79 references indexed in Scilit:
- Prospective Study of Survival Outcomes in Non-Hodgkin's Lymphoma Patients With Rheumatoid ArthritisJournal of Clinical Oncology, 2006
- Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancerEuropean Journal of Cancer, 2005
- History of Diabetes, Clinical Features of Prostate Cancer, and Prostate Cancer Recurrence-Data from CaPSURETM (United States)Cancer Causes & Control, 2005
- Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal CancerJAMA, 2005
- Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?Diabetes & Metabolism, 2004
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationArthritis & Rheumatism, 2002
- Breast cancer and NSAID use: a meta-analysisBritish Journal of Cancer, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000